Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment

被引：76
|
作者：
Mansinho, Andre [1 ]
Macedo, Daniela [1 ]
Fernandes, Isabel [1 ,2 ]
Costa, Luis [1 ,2 ]
机构：
[1] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Dept Oncol, Lisbon, Portugal
[2] Inst Med Mol, Fac Med Lisboa, Div Oncol, Lisbon, Portugal
来源：
MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES | 2019年 / 1126卷
关键词：
INCREASED SURVIVAL; DOUBLE-BLIND; PHASE-III; DOCETAXEL; THERAPY; CABAZITAXEL; PREDNISONE; ENZALUTAMIDE; MITOXANTRONE; ABIRATERONE;
D O I：
10.1007/978-3-319-99286-0_7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 133
页数：17
相关论文
共 50 条
  • [1] Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
    Santos Amaral, Teresa Maria
    Macedo, Daniela
    Fernandes, Isabel
    Costa, Luis
    [J]. PROSTATE CANCER, 2012, 2012
  • [2] Identification of novel molecular targets for treatment of castration-resistant prostate cancer
    Moselhy, Jim
    Roy, Ram V.
    Suman, Suman
    Das, Trinath P.
    Ankem, Murali
    Damodaran, Chendil
    [J]. CANCER RESEARCH, 2015, 75
  • [3] Castration-resistant prostate cancer: potential targets and therapies
    Parray, Aijaz
    Siddique, Hifzur R.
    Nanda, Sanjeev
    Konety, Badrinath R.
    Saleem, Mohammad
    [J]. BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 267 - 276
  • [4] Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets
    Chi, Kim N.
    Bjartell, Anders
    Dearnaley, David
    Saad, Fred
    Schroeder, Fritz H.
    Sternberg, Cora
    Tombal, Bertrand
    Visakorpi, Tapio
    [J]. EUROPEAN UROLOGY, 2009, 56 (04) : 594 - 605
  • [5] Cabazitaxel for the treatment of castration-resistant prostate cancer
    Agarwal, Neeraj
    Sonpavde, Guru
    Sartor, Oliver
    [J]. FUTURE ONCOLOGY, 2011, 7 (01) : 15 - 24
  • [6] Castration-resistant Prostate cancer: Treatment is differentiated
    Wolff, Johannes M.
    [J]. AKTUELLE UROLOGIE, 2011, 42 (02)
  • [7] Optimal treatment for castration-resistant prostate cancer
    Izumi, Kouji
    Namiki, Mikio
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 498 - 498
  • [8] Darolutamide for treatment of castration-resistant prostate cancer
    Rhea, L. P.
    Mendez-Marti, S.
    Aragon-Ching, J. B.
    [J]. DRUGS OF TODAY, 2020, 56 (03) : 185 - 193
  • [9] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    [J]. UROLOGE, 2020, 59 (06): : 673 - 679
  • [10] ENZALUTAMIDE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
    Ha, Y-S
    Goodin, S.
    DiPaola, R. S.
    Kim, I. Y.
    [J]. DRUGS OF TODAY, 2013, 49 (01) : 7 - 13
12345